SEMA3A and glioblastoma: Sema3A was also observed to promote, rather that inhibit, glioblastoma progression through the induction of tumor cells proliferation and macrophages recruitment and treatment with an anti-semaphorin-3A antibody inhibited the progression of glioblastoma tumors in mouse models [178].